Scientists hail revolutionary breast cancer breakthrough
Steve Connor is the Science Editor of The Independent. He has won many awards for his journalism, including five-times winner of the prestigious British science writers’ award; the David Perlman Award of the American Geophysical Union; twice commended as specialist journalist of the year in the UK Press Awards; UK health journalist of the year and a special merit award of the European School of Oncology for his investigative journalism. He has a degree in zoology from the University of Oxford and has a special interest in genetics and medical science, human evolution and origins, climate change and the environment.
Thursday 19 April 2012
A dramatic breakthrough in breast cancer research will lead to a revolution in the way the disease will be diagnosed and treated in years to come, leading cancer specialists said yesterday.
Researchers have discovered that breast cancer patients can be subdivided into ten different groups each with a unique genetic fingerprint that will determine the type of drugs and treatment that could lead to a cure.
Instead of looking at breast cancer as a single disease with a limited number of treatments, the scientists believe that it is now more accurate to view it as a range of illnesses with a wide variety of potential therapies that can be tailored to individual patients.
The discovery was made by analysing the tumours of some 2,000 women with breast cancer in a large Anglo-Canadian research effort, the biggest so far into understanding the genetics of a disease that kills nearly 12,000 people a year in Britain alone.
The study has also identified several new genes that are implicated in triggering or controlling breast cancer, which the scientists believe will become valuable targets for the development of novel anti-cancer drugs.
Harpal Kumar, chief executive of the charity Cancer Research UK, said that the landmark study will change the way clinical trials on new drugs and treatments are undertaken now that the complexities of the disease are more accurately understood.
“This in the years to come will have an enormous impact in the way we think about both diagnosing and treating women with breast cancer, and that should enable us to contine the progress we’ve made in breast cancer over the past 25 years,” Dr Kumar said.
The study, published in the journal Nature, involved more than a dozen research centres in Britain, Canada and Norway.
Apple's Tim Cook: Business isn’t just about making profit
Thousands of young people forced to go without food after benefits wrongly stopped under 'draconian' new sanctions regime
Ukraine crisis: New navy chief 'defects' and surrenders Crimean HQ as Putin claims ultranationalists forced intervention
Britain's top vet sparks controversy with call for ban on slashing animals' throats in 'ritual' slaughters for halal and kosher meat products
Ukraine crisis: Russia dismisses '3am ultimatum' as 'total nonsense'
If you're horrified by a flame-roasted dog, you should be shocked at a hog roast
- 1 The future of sex: The first female condoms were derided, mistrusted and shunned - but will their modern counterparts catch on?
- 2 South African rhino finally put down after roaming Kruger park for days with horn hacked off and bullet in brain
- 3 Italian pensioner hires an escort who turns out to be his son's girlfriend
- 4 Orgasm machine to deliver climax at the push of a button
- 5 Liam Neeson turned down James Bond role to marry Natasha Richardson
£12000 per annum: Inspiring Interns: A small but growing chain of boutique hot...
£12000 per annum: Inspiring Interns: The company works with Tier 1 FTSE 100 Ba...
£45 - 60k Per Annum: Charter Selection: Highly profitable leisure brand, marke...
£30000 - £50000 per annum + Highly Competitive Salary: Austen Lloyd: Residenti...